Furthermore, it has been previously reported that higher cancer stemness marker expressions were related to worse PFS in ovarian cancer patients [41], thus strengthening the potential for AhRR and PPP1R3C involvement in cancer stem cell regulation. The gene discussed is PPP1R3C; the disease is ovarian cancer.